Application 206939
- Type
- ANDA
- Sponsor
- BELCHER
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | CEFIXIME | CEFIXIME | FOR SUSPENSION;ORAL | 500MG/5ML | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 62250-668 | Cefixime | cefixime | Belcher Pharmaceuticals,LLC | ANDA | Current |
| 62250-668 | Cefixime | cefixime | Belcher Pharmaceuticals,LLC | ANDA | Current |
| 62250-668 | Cefixime | cefixime | Belcher Pharmaceuticals,LLC | ANDA | Current |
| 62250-668 | Cefixime | cefixime | Belcher Pharmaceuticals,LLC | ANDA | Current |
| 62250-668 | Cefixime | cefixime | Belcher Pharmaceuticals,LLC | ANDA | Current |